Atlas Trials

Imipenem/Cilastatin/Relebactam PK in ECMO

Clinical trial NCT04493151 · COMPLETED

Trial details

NCT number
NCT04493151
Sponsor
Joseph L. Kuti, PharmD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sepsis
Start date
2021-01-01
Primary completion
2023-05-31
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.